Who owns AstraZeneca?

Key details on AstraZeneca (Ticker: AZN)

Who owns AstraZeneca?

Is AZN a good stock to own? Find out who bought AstraZeneca, who sold AstraZeneca (AZN) stock, and who holds a large position in AstraZeneca.

Fund Name Number of Shares Share Valuation As Of
Wellington Management Company 25.45M $1.32B Sept. 30, 2013
Allianz Asset Management AG 10.41M $618.13M Dec. 31, 2013
FMR 8.69M $516.17M Dec. 31, 2013
UBS AG 5.81M $301.86M Sept. 30, 2013
Epoch Investment Partners 4.28M $253.89M Dec. 31, 2013
Federated Investors 4.10M $243.47M Dec. 31, 2013
MANAGED ACCOUNT ADVISORS 4.02M $238.42M Dec. 31, 2013
Schafer Cullen Capital Management 3.81M $226.28M Dec. 31, 2013
Hotchkis and Wiley Capital Management 3.69M $219.03M Dec. 31, 2013
ALLIANCEBERNSTEIN 3.00M $150.17M March 31, 2013
LETKO, BROSSEAU & ASSOCIATES 2.98M $176.71M Dec. 31, 2013
Renaissance Technologies 2.91M $151.31M Sept. 30, 2013
Tradewinds Global Investors 2.69M $121.73M June 30, 2012
Robeco Investment Management 2.63M $136.37M Sept. 30, 2013
Brandes Investment Partners 2.50M $148.65M Dec. 31, 2013
PUTNAM INVESTMENTS 2.33M $138.52M Dec. 31, 2013
GOLDMAN SACHS 2.29M $136.02M Dec. 31, 2013
BlackRock Advisors 2.16M $128.51M Dec. 31, 2013
Allianz Global Investors of America 2.10M $93.39M March 31, 2012
Hussman Econometrics Advisors 2.02M $96.53M Sept. 30, 2012
T. Rowe Price Associates 1.90M $113.01M Dec. 31, 2013
Capital World Investors^ 1.67M $99.15M Dec. 31, 2013
ClearBridge Advisors 1.63M $96.73M Dec. 31, 2013

Who sold AstraZeneca?

Fund Name Date Sold Number of Shares Sold Share Valuation
Credit Suisse AG March 31, 2013 2.43M $121.89M
HARRIS FINANCIAL Sept. 30, 2011 1.98M $87.82M